Key update bolstered Sonoma Pharmaceuticals (SNOA) stock price in the After hours

DBGI Stock

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) surged 25.82% to $9.6 in the after-hours session following the reports that it has entered into a non-exclusive distribution agreement with Gabriel Science, LLC for the sale of Microcyn Technology products into the dental market and it has already taken its first order. Sonoma manufactures Endocyn, a Microcyn Technology product, […]